These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 33059132)
61. Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies. Yakarsonmez S; Danis O; Mutlu O; Topuzogullari M; Sariyer E; Yuce-Dursun B; Turgut-Balik D Mol Divers; 2020 Nov; 24(4):1149-1164. PubMed ID: 31754915 [TBL] [Abstract][Full Text] [Related]
62. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1. Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659 [TBL] [Abstract][Full Text] [Related]
71. Identifying dual leucine zipper kinase (DLK) inhibitors using e-pharamacophore screening and molecular docking. Langeswaran K; Jeyaraman J; R JB; Biswas A; Dhurgadevi KR J Recept Signal Transduct Res; 2019 Apr; 39(2):99-105. PubMed ID: 31282287 [TBL] [Abstract][Full Text] [Related]
72. An in silico structural insights into Plasmodium LytB protein and its inhibition. Bhuyan R; Nandy SK; Seal A J Biomol Struct Dyn; 2015; 33(6):1198-210. PubMed ID: 25011618 [TBL] [Abstract][Full Text] [Related]
73. Trypanosomatid pin1-type peptidyl-prolyl isomerase is cytosolic and not essential for cell proliferation. Erben ED; Nardelli SC; de Jesus TC; Schenkman S; Tellez-Iñon MT J Eukaryot Microbiol; 2013; 60(1):101-5. PubMed ID: 23206323 [TBL] [Abstract][Full Text] [Related]
74. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Hennig L; Christner C; Kipping M; Schelbert B; Rücknagel KP; Grabley S; Küllertz G; Fischer G Biochemistry; 1998 Apr; 37(17):5953-60. PubMed ID: 9558330 [TBL] [Abstract][Full Text] [Related]
75. Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. Ferreira RS; Simeonov A; Jadhav A; Eidam O; Mott BT; Keiser MJ; McKerrow JH; Maloney DJ; Irwin JJ; Shoichet BK J Med Chem; 2010 Jul; 53(13):4891-905. PubMed ID: 20540517 [TBL] [Abstract][Full Text] [Related]
76. Solution structure of the single-domain prolyl cis/trans isomerase PIN1At from Arabidopsis thaliana. Landrieu I; Wieruszeski JM; Wintjens R; Inzé D; Lippens G J Mol Biol; 2002 Jul; 320(2):321-32. PubMed ID: 12079389 [TBL] [Abstract][Full Text] [Related]
77. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide. Mathur R; Chandna S; N Kapoor P; S Dwarakanath B Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380 [TBL] [Abstract][Full Text] [Related]
78. Simultaneous detection of Theileria annulata and Theileria orientalis infections using recombinase polymerase amplification. Hassan MA; Liu J; Sajid MS; Rashid M; Mahmood A; Abbas Q; Guan G; Yin H; Luo J Ticks Tick Borne Dis; 2018 May; 9(4):1002-1005. PubMed ID: 29625920 [TBL] [Abstract][Full Text] [Related]
79. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products. Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609 [TBL] [Abstract][Full Text] [Related]
80. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1. Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]